Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1

被引:63
作者
Morrison, LA [1 ]
Knipe, DM [1 ]
机构
[1] HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOLEC GENET,BOSTON,MA 02115
关键词
D O I
10.1006/viro.1996.0328
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have investigated the mechanisms by which subcutaneous immunization of mice with a replication-defective mutant of herpes simplex virus 1 protects against infection of the eye and latent infection of the trigeminal ganglion following corneal challenge. First, we have shown that immunization reduces the number of trigeminal ganglion neurons in challenged animals that express the latency-associated transcript. This indicates that the reduction in the incidence of latent infection by challenge virus is likely due to immune mechanisms and not saturation of the potential sites of latent infection by the immunizing mutant virus itself. Second, the duration of protective immunity against acute infection, keratitis, and latent infection was similar in mice immunized with replication-defective or -competent virus; thus, the replication-defective mutant virus is able to induce durable immunity apparently without spread in the host. Third, although the mutant virus showed no evidence of replication in vivo, it was present in footpad tissue in an infectious form for several days. This surprising observation raises the possibility that continued infection events by input virus over an extended period of time may have a boosting effect on the developing immune response which could explain, at least in part, the capacity of these replication-defective mutant viruses to elicit a robust and durable immunity despite their inability to spread within the host. (C) 1996 Academic Press, Inc.
引用
收藏
页码:402 / 413
页数:12
相关论文
共 60 条
[1]   Viral replication is required for induction of ocular immunopathology by herpes simplex virus [J].
Babu, JS ;
Thomas, J ;
Kanangat, S ;
Morrison, LA ;
Knipe, DM ;
Rouse, BT .
JOURNAL OF VIROLOGY, 1996, 70 (01) :101-107
[2]   IMMUNOGENICITY OF HERPES-SIMPLEX VIRUS TYPE-1 GLYCOPROTEINS EXPRESSED IN VACCINIA VIRUS RECOMBINANTS [J].
BLACKLAWS, BA ;
KRISHNA, S ;
MINSON, AC ;
NASH, AA .
VIROLOGY, 1990, 177 (02) :727-736
[3]  
BURKE RL, 1992, CURR TOP MICROBIOL, V179, P137
[4]  
BURKE RL, 1991, VIROLOGY, V181, P793
[5]  
CANTIN EM, 1983, P NATL ACAD SCI USA, V80, P7155
[6]   LOW-LEVELS OF HERPES-SIMPLEX VIRUS THYMIDINE THYMIDYLATE KINASE ARE NOT LIMITING FOR SENSITIVITY TO CERTAIN ANTIVIRAL DRUGS OR FOR LATENCY IN A MOUSE MODEL [J].
COEN, DM ;
IRMIERE, AF ;
JACOBSON, JG ;
KERNS, KM .
VIROLOGY, 1989, 168 (02) :221-231
[7]  
*COMM CAR US LAB A, 1985, GUID CAR US LAB AN, P85
[8]   ENHANCED IMMUNITY TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ENVELOPE ELICITED BY A COMBINED VACCINE REGIMEN CONSISTING OF PRIMING WITH A VACCINIA RECOMBINANT EXPRESSING HIV ENVELOPE AND BOOSTING WITH GP160-PROTEIN [J].
COONEY, EL ;
MCELRATH, MJ ;
COREY, L ;
HU, SL ;
COLLIER, AC ;
ARDITTI, D ;
HOFFMAN, M ;
COOMBS, RW ;
SMITH, GE ;
GREENBERG, PD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :1882-1886
[9]  
COREY L, 1991, REV INFECT DIS, V13, pS904
[10]   INDUCTION OF CYTOTOXIC T-LYMPHOCYTES BY RECOMBINANT CANARYPOX (ALVAC) AND ATTENUATED VACCINIA (NYVAC) VIRUSES EXPRESSING THE HIV-1 ENVELOPE GLYCOPROTEIN [J].
COX, WI ;
TARTAGLIA, J ;
PAOLETTI, E .
VIROLOGY, 1993, 195 (02) :845-850